Life Sciences Review has awarded Andira Pharmaceuticals the Top Therapeutic & Medical Device Products Provider 2023, and feature Andira in the August 17, 2023 issue with CEO, Dana Lambert, PhD…
Opportunity to invest in Canadian health science firm pioneering a new generation of patented therapeutics for drug-resistant infection is now open globally to eligible investors. SAN FRANCISCO, AUGUST 2023 –…
Through a Collaborative Research Agreement with Canada Research Chair in Oncology Dr. Karla Williams at the University of British Columbia Vancouver, British Columbia, Canada–Andira Pharmaceuticals announces it will carry out…
Vancouver, British Columbia, Canada– Andira Pharmaceuticals is proud to welcome Janette Lyons as Chief Financial Officer (CFO). Janette is a senior finance and business leader with over 15 years of…
VANCOUVER, BC, May 31, 2022 – Andira Pharmaceuticals is proud to announce the hiring of Eurofins Discovery to conduct pre-clinical research on Andira’s lead asset, a cannabinoid-based injectable antibiotic for…
Vancouver, BC - Andira Pharmaceuticals is pleased to welcome Ryan Miller to the Advisory Board. Mr. Miller is a finance veteran with over 15 years of experience in Corporate Finance,…
Vancouver, BC Canada - Andira Pharmaceuticals is pleased to announce it has retained MCRA LLC, a world leading global medical device, regulatory and clinical research consulting firm based in Washington,…
Vancouver, July 7, 2021– Andira Pharmaceuticals today announces it has secured an exclusive worldwide license for a portfolio of three cannabinoid antibiotic technologies along with their complementary drug delivery systems…
Vancouver, British Columbia, Canada– Andira Pharmaceuticals welcomes to its board of directors, Dr. Ethan Russo, a global pioneer in the development of cannabinoid therapeutics. Andira is a privately-held biopharmaceutical firm…
Vancouver, British Columbia, Canada– To protect novel anti-infective formulations developed at The University of British Columbia (UBC) for the treatment of Enterococcus, including the multi-drug-resistant superbug VRE, a Patent Cooperation…
Andira is a private healthcare company leveraging natural drug substances to improve lives and address critical illnesses. The company is advancing urgently needed solutions for highly prevalent medical indications in three areas: hospital acquired infection, oncology and dermatology.
Join our mailing list for our periodic general business, fundraising and scientific updates.
Copyright © 2023 Andira Pharmaceuticals
